People taking both a statin and a nonstatin to lower cholesterol levels had a 95% increased risk of Parkinson’s compared to people taking neither according to a new study.
Nonstatin cholesterol-lowering drugs included fenoﬁbrate (Trilipix, Tricor, Triglide, Antara, Lipofen, Fibricor, Lofibra, and Fenoglide), ezetimibe (Zetia), and niacin.
This study found that the most popular statins increase the risk of Parkinson’s Disease by 58%.
These are the lipophilic statins, meaning that they dissolve in fats, which include atorvastatin (Lipitor), ﬂuvastatin (Lescol), lovastatin (Mevacor), pitavastatin (Livalo), simvastatin (Zocor).
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.